source
- STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drugCEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.STAT · 1mo ago↗ source
- STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbookTrump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.STAT · 1mo ago↗ source
- STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancerYou’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here. We’re ASCOmaxxing. Rest…STAT